98%
921
2 minutes
20
Context: Micro-RNA have emerged as an important class of short endogenous RNA that act as posttranscriptional regulators of gene expression and are constantly deregulated in human cancer. MiR-1 has been found down-regulated in lung, colon, and prostate cancer.
Objectives: In this study, we investigated the possible role of miR-1 in thyroid carcinogenesis.
Design: We have analyzed miR-1 expression in a panel of thyroid neoplasias including benign and malignant lesions and searched for miR-1 targets.
Results: Our results show that miR-1 expression is drastically down-regulated in thyroid adenomas and carcinomas in comparison with normal thyroid tissue. Interestingly, miR-1 down-regulation was also found in thyroid hyperproliferative nonneoplastic lesions such as goiters. We identified the CCND2, coding for the cyclin D2 (CCND2) protein that favors the G1/S transition, CXCR4, and SDF-1α genes, coding for the receptor for the stromal cell derived factor-1 (SDF-1)/CXCL12 chemokine and its ligand SDF-1/CXCL12, respectively, as miR-1 targets. An inverse correlation was found between miR-1 expression and CXC chemokine receptor 4 (CXCR4) and SDF-1α protein levels in papillary and anaplastic thyroid carcinomas. Consistent with a role of the CCND2 protein in cell proliferation and CXCR4 and SDF-1α proteins in cell invasion and metastasis, functional studies demonstrate that miR-1 is able to inhibit thyroid carcinoma cell proliferation and migration.
Conclusions: These results indicate the involvement of miR-1 in thyroid cell proliferation and migration, validating a role of miR-1 down-regulation in thyroid carcinogenesis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1210/jc.2011-0345 | DOI Listing |
Background: At present, existing risk scores together with traditional biomarkers such as troponin and brain natriuretic peptide (BNP) are still unable to accurately predict cancer therapy-related cardiac dysfunction (CTRCD). MicroRNAs (miRNAs) have emerged as promising biomarkers for improved identification of high-risk patients; however, limited studies have been performed in patients with HER2-positive breast cancer.
Objectives: To investigate the predictive potential of six serum-derived circulating miRNAs for CTRCD occurrence in patients with early-stage HER2-positive breast cancer receiving trastuzumab (TTZ).
Front Immunol
September 2025
MetaLife Center, Shenzhen Institute of Translational Medicine, Shenzhen, Guangdong, China.
Introduction: Type 2 diabetes (T2D) is characterized by insulin resistance and chronic inflammation, with macrophages playing a crucial role in pancreatic islet dysfunction. This study explored the intersection of macrophage-specific gene expression and abnormal blood monovalent inorganic cation concentration-related genes (ABRGs) in T2D patients via single-cell RNA sequencing (scRNA-seq) and machine learning to identify key genes and potential therapeutic targets.
Methods: ScRNA-seq data from the pancreatic islet cells of 27 nondiabetic (ND) patients and 17 T2D patients were analyzed to identify differentially expressed genes (DEGs) in macrophages.
Am J Physiol Heart Circ Physiol
August 2025
Division of Cardiology, Leviev Cardiovascular & Thoracic Center, Chaim Sheba Medical Center, Tel Hashomer affiliated to School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
Background: Transcatheter aortic valve replacement (TAVR) is an increasingly common procedure for treating severe aortic stenosis. While cardiac biomarker elevation post-TAVR is common, its correlation with outcomes remains controversial. MicroRNAs (miRNAs) have emerged as potential biomarkers in cardiovascular diseases.
View Article and Find Full Text PDFPLoS One
August 2025
Bioinformatics Lab (Dry), Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh.
Introduction: Type 2 diabetes (T2D) is considered as a risk factor for kidney cancer (KC). However, so far, there is no study in the literature that has explored genetic factors through which T2D drive the development and progression of KC. Therefore, this study attempted to explore T2D- and KC-causing shared key genes (sKGs) for revealing shared pathogenesis and therapeutic drugs as their common treatments.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2025
Department of Gynecology and Obstetrics, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People's Hospital, Yichang, China.
Background: The early diagnosis and treatment of recurrent miscarriage are essential for preventing adverse pregnancy outcomes. This study explores the value of iron apoptosis-related gene in the diagnosis of recurrent pregnancy loss (RPL).
Methods: We obtained ferroptosis-related differentially expressed genes (DEGs) associated with RPL from the GEO database and the FerrDb database.